We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 5UCR | 2017 | 0 |
| 5UFT | 2017 | 0 |
| 5UJF | 2017 | 0 |
| 5UJU | 2017 | 0 |
| 5UM0 | 2017 | 0 |
| 5UNL | 2017 | 0 |
| 5UXV | 2018 | 0 |
| 5UXW | 2018 | 0 |
| 5UZH | 2017 | 0 |
| 5V0R | 2017 | 0 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 6vxx | 6vyb | https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7337389/ | Glycans on the SARS-CoV-2 spike control the receptor binding domain conformation | 2020 | R Henderson, RJ Edwards, K Mansouri, K Janowska- bioRxiv, 2020 - ncbi.nlm.nih.gov | this map yielding a structure aligning to the unmutated 2P structure ( PDB ID 6VXX ) with a one RBD 'up' state structure fit to this map to its unmutated counterpart ( PDB ID 6VYB N234A mutation (Figure 3E and andF).F). However, the limited resolution of this structure limits close |
| 2 | 6wps | - | https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7457611/ | Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies | 2020 | CO Barnes, CA Jette, ME Abernathy, KMA Dam- bioRxiv, 2020 - ncbi.nlm.nih.gov | 1g) that were isolated from the same donor 5 . They share structural similarities with each other and with other VH353/short 1) and C144 Fab (from C144-S structure ) aligned on a RBD monomer. ACE2 ( PDB 6M0J; light green surface) is aligned on the same RBD for reference ... Composite model of C135-RBD (blue and gray, respectively) overlaid with the SARS-CoV-2 NAb S309 (sand, PDB 6WPS) and soluble ACE2 |
| 3 | 6vxx | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505244/ | Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin | 2020 | P Bhanu, NH Kumar, SH Kumar, M Relekar- , 2020 - ncbi.nlm.nih.gov | PDB ID, Ligand, Binding Pose, Binding Energy (Kcal/mol), RMSD, Receptor, Bond Length ( Figure 1a: Structural representation of 6VXX and thrombin, Figure 1b: Molecular interaction of with the 7th pose, Key - the sticks represents thrombin, the secondary structure represents the |
| 4 | 6wps | 6wpt | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586990/ | Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID19 | 2020 | J Huang, H Huang, D Wang, C Wang- Clinical and, 2020 - ncbi.nlm.nih.gov | Structural data of RBD of SARSCoV2 S protein with CR3022 Fab was retrieved from Protein Databank. (C) Structure of SARSCoV2 S protein with neutralizing antibody S309 Fab fragment ( PDB : 6WPS ) is shown in close state |
| 5 | 6tz8 | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669531/ | Current Challenges and Opportunities in Designing ProteinProtein Interaction Targeted Drugs | 2020 | WH Shin, K Kumazawa, K Imai- and Applications in, 2020 - ncbi.nlm.nih.gov | Phase Reached*, Modality*, Drug PDB ID**, Drug-Protein PDB ID*, Target PPI PDB ID binding protein 1A inhibitor, Inhibitor, Approved (1994), Small molecule, FK5, 1BKF, 6TZ8 (FKBP12/CNA 2.8 resolution by cryo-electron microscopy (cryo-EM).65 The cryo-EM structure revealed ... 6TZ8 (FKBP12/CNA/CNB) (C. neoformans) |
| 6 | 5VOG | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674647/ | Structural analysis of (p) ppGpp reveals its versatile binding pattern for diverse types of target proteins | 2020 | GS Kushwaha, A Patra, NS Bhavesh- Frontiers in microbiology, 2020 - ncbi.nlm.nih.gov | Although, glycosidic bond and ribose sugar in the nucleotide structure exhibit conformational flexibility and classical molecular dynamics simulation on nucleotides is S.No, Macromolecule Name, Resolution (), PDB ID 14, Putative phosphoribosyltransferase, 1.50, 5VOG |
| 7 | 3laa | 4lgo, 3s6l | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688925/ | Non-adaptive evolution of trimeric autotransporters in Brucellaceae | 2020 | MR Rahbar, M Zarei, A Jahangiri, S Khalili- Frontiers in, 2020 - ncbi.nlm.nih.gov | domain from Haemophilus influenzae genome ( PDB ID:1S7M; Yeo et al., 2004); structure of the parallel beta-roll collagen-binding domain of Yersinia enterocolitica adhesin YadA ( PDB ID: 1P9H Batch analyzes of the dataset suggested the existence of a few structural domains |
| 8 | 4g6c | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744477/ | New Putative Antimicrobial Candidates: In silico Design of Fish-Derived Antibacterial Peptide-Motifs | 2020 | H Okella, JJ Georrge, S Ochwo, C Ndekezi- Frontiers in, 2020 - ncbi.nlm.nih.gov | a global docking procedure in four folds, motif-based prediction based on peptide conformation, rigid-body docking, scoring based on structural clustering; and final structure minimization. ... The affinity of peptide-motifs A15_B and A15_E was highest within chains of the target proteins (PDB ID 1rrv, 4g6c, and 4oj8). |
| 9 | 4ol9 | 4qji | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770189/ | Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents | 2020 | HS Butman, TJ Kotz, CS Dowd- Frontiers in Cellular and, 2020 - ncbi.nlm.nih.gov | This review gathers literature reports on the structure /mechanism, inhibitors, and vulnerability of each enzyme in the CoA pathway... To date, there is very little information available for the Mtb PanE homologue (MtPanE). The activity of the protein expressed by the putative panE gene (Rv2573) has not been experimentally verified, although its crystal structure bound to NADP+ and oxamate has been solved (PDB ID: 4OL9). |
| 10 | 5ji5 | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080978.3/ | Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches | 2021 | G Selvaraj, S Kaliamurthi, GH Peslherbe- F1000Research, 2021 - ncbi.nlm.nih.gov | Structural modeling approach to study host-SARS-CoV-2 proteins interaction and drug and similarity and with the highest resolution template automatically from PDB and then Then, the corresponding structures constructed by superimposing the modeled protein structure on to |